Open AccessProactive use of eltrombopag before the onset of clinical bleeding in two children with immune thrombocytopenia and lifestyle restrictions
Author(s) -
Bergmann Shayla
Publication year - 2017
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.1086
Subject(s) - eltrombopag , medicine , immune thrombocytopenia , pediatrics , major bleeding , intensive care medicine , platelet , myocardial infarction
Key Clinical Message Children with immune thrombocytopenia ( ITP ) are often managed using a watch‐and‐wait approach to avoid conventional treatment that may be poorly tolerated. However, in some patients, this approach may lead to lifestyle restrictions due to risk of injury‐related bleeding. Eltrombopag is a well‐tolerated new option that may help these children.